Sample Request

Global Plasma Protein Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

SELECT LICENSE:

Published on 08/13/2021| Code: GINR42221| Category: Healthcare & Life Sciences| Total Pages: 109

The Plasma Protein Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Plasma Protein Therapeutics size is estimated to be USD 34800 million in 2026 from USD 27040 million in 2020, with a change % between 2020 and 2021. The global Plasma Protein Therapeutics market size is expected to grow at a CAGR of 6.5% for the next five years.

Market segmentation

Plasma Protein Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Coagulation Factor

Immune Globulin

Albumin

Others

Market segment by Application, can be divided into

Hemophilia

PID

Others

Market segment by players, this report covers

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Kamada

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

1 Market Overview

1.1 Product Overview and Scope of Plasma Protein Therapeutics

1.2 Classification of Plasma Protein Therapeutics by Type

1.2.1 Overview: Global Plasma Protein Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Type in 2020

1.2.3 Coagulation Factor

1.2.4 Immune Globulin

1.2.5 Albumin

1.2.6 Others

1.3 Global Plasma Protein Therapeutics Market by Application

1.3.1 Overview: Global Plasma Protein Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hemophilia

1.3.3 PID

1.3.4 Others

1.4 Global Plasma Protein Therapeutics Market Size & Forecast

1.5 Global Plasma Protein Therapeutics Market Size and Forecast by Region

1.5.1 Global Plasma Protein Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Plasma Protein Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Plasma Protein Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Plasma Protein Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Plasma Protein Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Plasma Protein Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Plasma Protein Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Plasma Protein Therapeutics Market Drivers

1.6.2 Plasma Protein Therapeutics Market Restraints

1.6.3 Plasma Protein Therapeutics Trends Analysis

2 Company Profiles

2.1 Shire (Baxalta)

2.1.1 Shire (Baxalta) Details

2.1.2 Shire (Baxalta) Major Business

2.1.3 Shire (Baxalta) Plasma Protein Therapeutics Product and Solutions

2.1.4 Shire (Baxalta) Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Shire (Baxalta) Recent Developments and Future Plans

2.2 CSL

2.2.1 CSL Details

2.2.2 CSL Major Business

2.2.3 CSL Plasma Protein Therapeutics Product and Solutions

2.2.4 CSL Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 CSL Recent Developments and Future Plans

2.3 Grifols

2.3.1 Grifols Details

2.3.2 Grifols Major Business

2.3.3 Grifols Plasma Protein Therapeutics Product and Solutions

2.3.4 Grifols Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Grifols Recent Developments and Future Plans

2.4 Octapharma

2.4.1 Octapharma Details

2.4.2 Octapharma Major Business

2.4.3 Octapharma Plasma Protein Therapeutics Product and Solutions

2.4.4 Octapharma Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Octapharma Recent Developments and Future Plans

2.5 Kedrion

2.5.1 Kedrion Details

2.5.2 Kedrion Major Business

2.5.3 Kedrion Plasma Protein Therapeutics Product and Solutions

2.5.4 Kedrion Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Kedrion Recent Developments and Future Plans

2.6 LFB Group

2.6.1 LFB Group Details

2.6.2 LFB Group Major Business

2.6.3 LFB Group Plasma Protein Therapeutics Product and Solutions

2.6.4 LFB Group Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 LFB Group Recent Developments and Future Plans

2.7 Biotest

2.7.1 Biotest Details

2.7.2 Biotest Major Business

2.7.3 Biotest Plasma Protein Therapeutics Product and Solutions

2.7.4 Biotest Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Biotest Recent Developments and Future Plans

2.8 BPL

2.8.1 BPL Details

2.8.2 BPL Major Business

2.8.3 BPL Plasma Protein Therapeutics Product and Solutions

2.8.4 BPL Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 BPL Recent Developments and Future Plans

2.9 RAAS

2.9.1 RAAS Details

2.9.2 RAAS Major Business

2.9.3 RAAS Plasma Protein Therapeutics Product and Solutions

2.9.4 RAAS Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 RAAS Recent Developments and Future Plans

2.10 CBPO

2.10.1 CBPO Details

2.10.2 CBPO Major Business

2.10.3 CBPO Plasma Protein Therapeutics Product and Solutions

2.10.4 CBPO Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 CBPO Recent Developments and Future Plans

2.11 Hualan Bio

2.11.1 Hualan Bio Details

2.11.2 Hualan Bio Major Business

2.11.3 Hualan Bio Plasma Protein Therapeutics Product and Solutions

2.11.4 Hualan Bio Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Hualan Bio Recent Developments and Future Plans

2.12 Kamada

2.12.1 Kamada Details

2.12.2 Kamada Major Business

2.12.3 Kamada Plasma Protein Therapeutics Product and Solutions

2.12.4 Kamada Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Kamada Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Plasma Protein Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Plasma Protein Therapeutics Players Market Share

3.2.2 Top 10 Plasma Protein Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Plasma Protein Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Plasma Protein Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Plasma Protein Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Plasma Protein Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Plasma Protein Therapeutics Revenue by Type (2016-2026)

6.2 North America Plasma Protein Therapeutics Revenue by Application (2016-2026)

6.3 North America Plasma Protein Therapeutics Market Size by Country

6.3.1 North America Plasma Protein Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Plasma Protein Therapeutics Revenue by Type (2016-2026)

7.2 Europe Plasma Protein Therapeutics Revenue by Application (2016-2026)

7.3 Europe Plasma Protein Therapeutics Market Size by Country

7.3.1 Europe Plasma Protein Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Plasma Protein Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Plasma Protein Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Plasma Protein Therapeutics Market Size by Region

8.3.1 Asia-Pacific Plasma Protein Therapeutics Revenue by Region (2016-2026)

8.3.2 China Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Plasma Protein Therapeutics Revenue by Type (2016-2026)

9.2 South America Plasma Protein Therapeutics Revenue by Application (2016-2026)

9.3 South America Plasma Protein Therapeutics Market Size by Country

9.3.1 South America Plasma Protein Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Plasma Protein Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Country

10.3.1 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Plasma Protein Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005